Marshall Wace’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Marshall Wace's HALO Position: Q1 2026 in Review
Marshall Wace reduced its Halozyme (HALO) stake by 76% in Q1 2026, selling an estimated $26.5M and leaving 121,006 shares worth $7.82M. The position accounts for 0.01% of the portfolio, ranked #1087.
Marshall Wace first reported a position in HALO in Q1 2019 and has held it in 15 quarters since. The position peaked at $104M in Q3 2023. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Marshall Wace held 121,006 shares of Halozyme worth $7.82M as of Q1 2026.
- Marshall Wace sold 376,194 Halozyme shares in Q1 2026, an estimated $26.5M.
- Halozyme made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1087 holding.
- Marshall Wace first reported a position in Halozyme in Q1 2019 and has held it in 15 quarters since.
- Marshall Wace's Halozyme position peaked at $104M in Q3 2023.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.